by admin | Dec 9, 2020 | press-releases
Home PRESS RELEASE CG Oncology Announces First Patient Dosed in Phase 2 Clinical Trial of cretostimogene grenadenorepvec, an Oncolytic Immunotherapy, in Combination with pembrolizumab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin π»...
by admin | Nov 12, 2020 | press-releases
Home PRESS RELEASE CG Oncology Announces First Patient Dosed in Phase 1b Study of Oncolytic Immunotherapy cretostimogene grenadenorepvec in Combination with nivolumab in Muscle-Invasive Bladder Cancer π» DESKTOP AUDIO PLAYER =============================== --> Listen...
by admin | Mar 26, 2020 | press-releases
Home PRESS RELEASE CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for cretostimogene grenadenorepvec in Japan and Other Asian Countries π» DESKTOP AUDIO PLAYER =============================== --> Listen to this...
by admin | Mar 15, 2019 | press-releases
Home PRESS RELEASE $22 Million Series C Financing π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to this article now 0:00 0.5x 0.75x Normal 1.25x 1.5x 1.75x β...
by admin | Nov 28, 2018 | press-releases
Home PRESS RELEASE Clinical Trial Collaboration to Evaluate the Combination of cretostimogene grenadenorepvec and pembrolizumab in Bladder Cancer π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER...
by admin | May 15, 2017 | press-releases
Home PRESS RELEASE Clinical Results at American Urological Association (AUA) Annual Meeting 2017 π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to this article...